- Home
- EOLS vs CAN Comparison
EOLS vs CAN Comparison
Compare EOLS & CAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EOLS
- CAN
- Stock Information
- Founded
- EOLS 2012
- CAN 2013
- Country
- EOLS United States
- CAN Singapore
- Employees
- EOLS N/A
- CAN N/A
- Industry
- EOLS Biotechnology: Pharmaceutical Preparations
- CAN Semiconductors
- Sector
- EOLS Health Care
- CAN Technology
- Exchange
- EOLS Nasdaq
- CAN Nasdaq
- Market Cap
- EOLS 444.0M
- CAN 511.2M
- IPO Year
- EOLS 2018
- CAN 2019
- Fundamental
- Price
- EOLS $7.03
- CAN $0.93
- Analyst Decision
- EOLS Strong Buy
- CAN Strong Buy
- Analyst Count
- EOLS 4
- CAN 7
- Target Price
- EOLS $21.25
- CAN $3.64
- AVG Volume (30 Days)
- EOLS 2.0M
- CAN 36.6M
- Earning Date
- EOLS 11-05-2025
- CAN 11-18-2025
- Dividend Yield
- EOLS N/A
- CAN N/A
- EPS Growth
- EOLS N/A
- CAN N/A
- EPS
- EOLS N/A
- CAN N/A
- Revenue
- EOLS $285,823,000.00
- CAN $422,228,000.00
- Revenue This Year
- EOLS $13.39
- CAN $78.34
- Revenue Next Year
- EOLS $26.85
- CAN $50.58
- P/E Ratio
- EOLS N/A
- CAN N/A
- Revenue Growth
- EOLS 15.10
- CAN 83.87
- 52 Week Low
- EOLS $5.71
- CAN $0.53
- 52 Week High
- EOLS $17.12
- CAN $3.27
- Technical
- Relative Strength Index (RSI)
- EOLS 53.48
- CAN 42.47
- Support Level
- EOLS $6.53
- CAN $0.86
- Resistance Level
- EOLS $7.01
- CAN $0.99
- Average True Range (ATR)
- EOLS 0.41
- CAN 0.12
- MACD
- EOLS -0.01
- CAN -0.01
- Stochastic Oscillator
- EOLS 45.53
- CAN 22.18
About EOLS Evolus Inc.
Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.
About CAN Canaan Inc.
Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment and the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts and accessories. Geographically, the company derives its maximum revenue from United States.